GENEVA, May 17 -- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD (Zone A, 4F, 289 Digitland, 2 Hongliu Road, Futian DistrictShenzhen, Guangdong 518017), 深圳信立泰药业股份有限公司 (中国广东省深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区) filed a patent application (PCT/CN2024/130410) for "MULTI-RECEPTOR CO-AGONIST COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF" on Nov 07, 2024. With publication no. WO/2025/098422, the details related to the patent application was published on May ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.